Where I see patients (3)
My reviews
Selected research
-
Stereotactic magnetic resonance imaging-guided adaptive radiotherapy: a pooled analysis of a master prospective trial.
Journal of the National Cancer Institute
-
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
European urology
-
Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy.
Physics and imaging in radiation oncology
5.0